SCHEDULE: Ronda Stryker Amends Stake in Stryker Corp

Ronda E. Stryker has updated her Schedule 13D filing to report a change of at least 1% in her beneficial ownership of Stryker Corp common stock.

Summary

• Ronda E. Stryker, a director of Stryker Corp, has filed an amendment to her Schedule 13D, reporting a change of at least 1% in her beneficial ownership of the company's common stock.
• As of the filing date, she beneficially owns an aggregate of 15,223,331 shares, representing 4.0% of the class of securities.
• This amendment reflects transactions within the 60 days prior to the filing, including the exercise of options, a gift of shares, a sale of shares, and a transfer of shares.
• Stryker intends to continuously evaluate her investment and may acquire or dispose of shares based on market conditions and her best interests.
• She may share voting and dispositive power over shares held by her husband, William D. Johnston, and shares held in the LLS Subtrust and the Foundation, where she is a trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it's a routine update on beneficial ownership and insider activity, not indicative of significant positive or negative company performance.

Positives

• Ronda E. Stryker continues to hold a significant stake (4.0%) in Stryker Corp, indicating ongoing confidence in the company.
• The filing details active management of her holdings, including exercising options and strategic gifting/selling, which can be seen as prudent financial management.
• She retains flexibility to acquire or dispose of shares, allowing for adaptation to market conditions.

Negatives

• The filing indicates a sale of 500,000 shares, which could be interpreted as a reduction in direct holdings, although it is part of a broader strategy.
• The complexity of shared voting and dispositive power across various trusts and entities could lead to potential governance complexities or differing interests.

Risks

• Potential for further sales of shares by Ronda E. Stryker or entities over which she may share control, which could impact share price.
• The ongoing evaluation of her investment and potential for acquisitions or disposals introduces an element of uncertainty regarding her future stake.
• The filing notes that Greenleaf Trust holds shares in a fiduciary capacity for customers, some of whom have rights to dividends or sale proceeds, adding a layer of complexity to ultimate beneficial ownership and control.

Future Outlook

Ronda E. Stryker intends to continuously evaluate her investment in Stryker Corp and her options. She and her husband may acquire additional shares through option exercises, equity awards, or market purchases, and may dispose of shares through various means, including public or private sales, gifts, or forfeitures.

Management Comments

• Ronda E. Stryker intends to evaluate on an ongoing basis her investment in the Company and her options with respect to such investment.
• Ronda E. Stryker and her husband may, from time to time, acquire additional Common Shares by the exercise or additional vesting of options, by the grant of additional options or other equity awards by the Company or from time to time for investment purposes if market conditions are favorable, in the open market, in privately negotiated transactions or otherwise.
• Ronda E. Stryker and her husband may also dispose of some or all of the Companys Common Shares that they beneficially own, periodically, by public or private sale (registered or unregistered and with or without the simultaneous sale of newly-issued Common Shares by the Company), gift, expiration of options, forfeiture of restricted shares or otherwise, including, without limitation, sales of Common Shares pursuant to Rule 144 under the Securities Act of 1933, as amended, or otherwise.
• Ronda E. Stryker and her husband reserve the right not to acquire Common Shares at any given time and not to dispose of all or part of Common Shares they may own at any given time if they determine such acquisition or disposal is not in their best interests at the time in question.

Industry Context

StockSavvy.ai notes that this Schedule 13D filing by a significant insider like Ronda E. Stryker, who is also a director and related to the founder, is a common occurrence for large-cap healthcare companies. Such filings provide transparency on insider holdings and potential shifts in ownership, which are closely watched by the market.

Related Party Transactions

• Ronda E. Stryker may be deemed to share voting and investment power over shares held by her husband, William D. Johnston.
• Ronda E. Stryker may be deemed to share voting and dispositive power over shares held in the LLS Subtrust, where she has a special power of appointment and the power to change the trustee.
• Ronda E. Stryker may be deemed to share voting and investment power over shares held in the Foundation, as she is a trustee and decisions are controlled by majority vote of trustees.
• Greenleaf Trust, where Ronda E. Stryker is a shareholder and director, and her husband is the controlling shareholder, holds shares in a fiduciary capacity. Some beneficiaries of these trusts have the right to receive dividends or direct sale proceeds.

Stakeholder Impact

• Shareholders: The filing provides transparency on a significant insider's holdings and potential future trading activity, which can influence market perception.
• Management/Board: The active management of holdings by a director like Ronda E. Stryker reflects ongoing engagement with the company's performance and value.
• Employees: Indirect impact through potential share price fluctuations influenced by insider trading disclosures.

Next Steps

• Ronda E. Stryker will continue to monitor her investment and may engage in further acquisitions or dispositions of Stryker Corp shares.
• The company's stock performance and market conditions will influence future transactions by Ms. Stryker and her husband.

Key Dates

Keywords

Stryker Corp, Schedule 13D, Ronda E. Stryker, Beneficial Ownership, Common Stock, Insider Trading, SEC Filing, Shareholder, Director, Investment Strategy